Details for Patent: 5,676,968
✉ Email this page to a colleague
Summary for Patent: 5,676,968
Title: | Transdermal therapeutic systems with crystallization inhibitors |
Abstract: | A transdermal therapeutic system is described, which is characterized in that it contains a crystallization inhibitor and optionally penetration enhancer in an active ingredient-containing adhesive matrix. |
Inventor(s): | Lipp; Ralph (Berlin, DE), Riedl; Jutta (Berlin, DE), Tack; Johannes (Berlin, DE) |
Assignee: | Schering Aktiengesellschaft (Berlin, DE) |
Application Number: | 08/433,557 |
Patent Claim Types: see list of patent claims | Compound; |
Drugs Protected by US Patent 5,676,968
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,676,968
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Germany | 41 36 057.5 | Oct 31, 1991 |
Germany | 42 10 711.3 | Mar 27, 1992 |
International Family Members for US Patent 5,676,968
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 158181 | ⤷ Try a Trial | |||
Australia | 1652997 | ⤷ Try a Trial | |||
Australia | 2895392 | ⤷ Try a Trial | |||
Australia | 712692 | ⤷ Try a Trial | |||
Canada | 2120599 | ⤷ Try a Trial | |||
Germany | 4210711 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |